QUARTERLY RESULTS (UNAUDITED) (DETAILS) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended																12 Months Ended
	Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2012		Sep. 30, 2012		Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2012
NET SALES	$ 20,157		$ 20,178		$ 21,897		$ 20,830		$ 20,297		$ 20,205		$ 21,737		$ 20,342		$ 83,062		$ 82,581		$ 82,006
OPERATING INCOME	3,240		3,405		4,523		4,120		2,651	[1]	3,361		4,429		3,889		15,288		14,330		13,035
GROSS MARGIN	47.20%		48.60%		50.30%		49.20%		47.90%		50.00%		51.20%		50.30%		48.90%		49.90%
NET EARNINGS:
NET EARNINGS FROM CONTINUING OPERATIONS	2,611		2,603		3,454		3,039		1,893	[1]	2,562		4,034	[2]	2,812		11,707		11,301		9,150
Net earnings from discontinued operations	9		33		18		18		(11)		29		42		41		78		101		1,754
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	$ 2,579		$ 2,609		$ 3,428		$ 3,027		$ 1,875	[1]	$ 2,566		$ 4,057	[2]	$ 2,814		$ 11,643		$ 11,312		$ 10,756
DILUTED NET EARNINGS PER COMMON SHARE:
Earnings from continuing operations	$ 0.89	[3]	$ 0.89	[3]	$ 1.17	[3]	$ 1.03	[3]	$ 0.64	[3]	$ 0.87	[3]	$ 1.38	[3]	$ 0.95	[3]	$ 3.98	[3],[4]	$ 3.83	[3],[4]	$ 3.06	[4]
Earnings from discontinued operations	$ 0.00	[3]	$ 0.01	[3]	$ 0.01	[3]	$ 0.01	[3]	$ 0.00	[3]	$ 0.01	[3]	$ 0.01	[3]	$ 0.01	[3]	$ 0.03	[3],[4]	$ 0.03	[3],[4]	$ 0.60	[4]
Diluted net earnings per common share	$ 0.89	[3]	$ 0.90	[3]	$ 1.18	[3]	$ 1.04	[3]	$ 0.64	[3]	$ 0.88	[3]	$ 1.39	[3]	$ 0.96	[3]	$ 4.01	[3],[4]	$ 3.86	[3],[4]	$ 3.66	[4]

[1] During the fourth quarter of fiscal year 2013, the Company recorded before-tax goodwill and indefinite-lived intangible assets impairment charges of $308 ($290 after-tax). For additional details, see Note 2.

[2] The Company acquired the balance of its Baby Care and Feminine Care joint venture in Iberia in October 2012 resulting in a non-operating gain of $623.

[3] Diluted net earnings per share is calculated on earnings attributable to Procter & Gamble.

[4] Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble